RLMD
RELMADA THERAPEU (RLMD)
NASDAQ
$5.22-$0.09 (-1.79%)
Price as of Aug 03, 2026 11:34 AM EDT
  • $557.5M
    Market Cap
  • 799.39%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
JANUS HENDERSON GROUP PLC
10.55%
11.1M
+3.8M (+34.29%)
Mar 31, 2026
N/A
8.08%
8.5M
+1.8M (+20.94%)
Mar 31, 2026
VR ADVISER, LLC
4.62%
4.8M
+4.8M (+100.00%)
Mar 31, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.
4.54%
4.8M
+493,158 (+10.35%)
Mar 31, 2026
ORBIMED ADVISORS LLC
4.50%
4.7M
+2.1M (+44.64%)
Mar 31, 2026
MARSHALL WACE, LLP
4.27%
4.5M
+1.3M (+28.83%)
Mar 31, 2026
MILLENNIUM MANAGEMENT LLC
3.73%
3.9M
+2.2M (+57.18%)
Mar 31, 2026

Current Ownership Distribution

  • Institutions370.2M (87.58%)
  • Mutual Funds47.6M (11.26%)
  • Insiders4.9M (1.16%)
  • Other0 (0.00%)

Insider Transactions

  • 1.16% (4.9M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 0
    Number of InsiderSelling (last 12 months)
  • $0.00
    Amount of InsiderSelling (last 12 months)
No data found

No data found